文献速递生殖医学妇科

子宫内膜异位症相关不孕女性辅助生殖技术的预后因素

Prognostic factors for assisted reproductive technology in women with endometriosis-related infertility.
PubMed 文献 · Am J Obstet Gynecol · 2016-11-27

该回顾性观察性队列研究纳入2005年6月至2013年2月期间在一所大学医院接受体外受精或卵胞浆内单精子注射的359例子宫内膜异位症患者,共720个辅助生殖技术周期。结果显示子宫内膜异位症表型对辅助生殖技术结局似乎无影响,而既往子宫内膜异位症手术史、子宫内膜瘤手术史、抗苗勒管激素<2 ng/mL及窦卵泡计数<10与较低的妊娠率相关。

要点

  • 子宫内膜异位症表型(表浅腹膜型、子宫内膜瘤、深部浸润型)对辅助生殖技术结局似乎无影响。
  • 既往子宫内膜异位症手术史(OR 0.14)和子宫内膜瘤手术史(OR 0.39)与较低的妊娠率独立相关。
  • 抗苗勒管激素<2 ng/mL(OR 0.51)和窦卵泡计数<10(OR 0.27)与不良辅助生殖技术结局相关。

核心结论

  • 子宫内膜异位症表型似乎对辅助生殖技术结果无影响,卵巢储备改变以及既往子宫内膜异位症和/或子宫内膜瘤手术与妊娠率降低相关。

研究设计与样本

  • 这是一项回顾性观察性队列研究,纳入2005年6月至2013年2月期间在一所大学医院连续接受体外受精或卵胞浆内单精子注射的359例子宫内膜异位症患者。
  • 根据影像学标准(经阴道超声、磁共振成像)将子宫内膜异位病变分为3种表型:表浅腹膜型子宫内膜异位症、子宫内膜瘤或深部浸润型子宫内膜异位症;有子宫内膜异位症手术史的女性经组织学证据确诊。
  • 主要结局指标为每周期和每胚胎移植的临床妊娠率与活产率,采用单因素和多因素校正逻辑回归模型比较妊娠与未妊娠女性以识别预后因素。

主要发现

  • 359例子宫内膜异位症患者共接受720个辅助生殖技术周期,158例(44%)患者妊娠,114例(31.8%)活产。
  • 每胚胎移植的临床妊娠率为36.4%,活产率为22.8%。
  • 子宫内膜异位症表型(表浅子宫内膜异位症、子宫内膜瘤或深部浸润型子宫内膜异位症)对辅助生殖技术结局无影响。
  • 多因素分析后,既往子宫内膜异位症手术史(OR 0.14,95%CI 0.06-0.38)或既往子宫内膜瘤手术史(OR 0.39,95%CI 0.18-0.84)是与较低妊娠率相关的独立因素。
  • 抗苗勒管激素水平<2 ng/mL(OR 0.51,95%CI 0.28-0.91)和窦卵泡计数<10(OR 0.27,95%CI 0.14-0.53)也与不良辅助生殖技术结局相关。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Assisted reproductive technology is one of the therapeutic options offered for managing endometriosis-associated infertility. Yet, published data on assisted reproductive technology outcome in women affected by endometriosis are conflicting and the determinant factors for pregnancy chances unclear. OBJECTIVE: We sought to evaluate assisted reproductive technology outcomes in a series of 359 endometriosis patients, to identify prognostic factors and determine if there is an impact of the endometriosis phenotype. STUDY DESIGN: This was a retrospective observational cohort study, including 359 consecutive endometriosis patients undergoing in vitro fertilization or intracytoplasmic sperm injection, from June 2005 through February 2013 at a university hospital. Endometriotic lesions were classified into 3 phenotypes-superficial peritoneal endometriosis, endometrioma, or deep infiltrating endometriosis-based on imaging criteria (transvaginal ultrasound, magnetic resonance imaging); histological proof confirmed the diagnosis in women with a history of surgery for endometriosis. Main outcome measures were clinical pregnancy rates and live birth rates per cycle and per embryo transfer. Prognostic factors of assisted reproductive technology outcome were identified by comparing women who became pregnant and those who did not, using univariate and adjusted multiple logistic regression models. RESULTS: In all, 359 endometriosis patients underwent 720 assisted reproductive technology cycles. In all, 158 (44%) patients became pregnant, and 114 (31.8%) had a live birth. The clinical pregnancy rate and the live birth rate per embryo transfer were 36.4% and 22.8%, respectively. The endometriosis phenotype (superficial endometriosis, endometrioma, or deep infiltrating endometriosis) had no impact on assisted reproductive technology outcomes. After multivariate analysis, history of surgery for endometriosis (odds ratio, 0.14; 95% confidence ratio, 0.06-0.38) or past surgery for endometrioma (odds ratio, 0.39; 95% confidence ratio, 0.18-0.84) were independent factors associated with lower pregnancy rates. Anti-müllerian hormone levels <2 ng/mL (odds ratio, 0.51; 95% confidence ratio, 0.28-0.91) and antral follicle count <10 (odds ratio, 0.27; 95% confidence ratio, 0.14-0.53) were also associated with negative assisted reproductive technology outcomes. CONCLUSION: The endometriosis phenotype seems to have no impact on assisted reproductive technology results. An altered ovarian reserve and a previous surgery for endometriosis and/or endometrioma are associated with decreased pregnancy rates.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Maignien C, Santulli P, Gayet V, et al. Prognostic factors for assisted reproductive technology in women with endometriosis-related infertility. Am J Obstet Gynecol. 2016. PMID: 27899313. doi:10.1016/j.ajog.2016.11.1042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。